Clinical Trial Update: A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating whether an amino acid formulation reduces pain and numbness in people with peripheral neuropathy, including diabetic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Diabetic Neuropathy
• Hiv-associated Neuropathy
• Traumatic Neuropathy

Drugs mentioned

• Amino acid formulation

Snippet

Sponsor: Targeted Medical Pharma | Conditions: Diabetic Neuropathy, Chemotherapy Induced Neuropathy | Phase 2 | Status: UNKNOWN